Calcium ion blocking drugs
Resnekov, L.
Comprehensive Therapy 8(7): 10-15
1982
ISSN/ISBN: 0098-8243 PMID: 7116804 Document Number: 186684
Document emailed within 1 workday
Related Documents
Brill, D.M.; Fozzard, H.A. 1985: Calcium channel blocking drugs. Part II: Clinical applications Comprehensive Therapy 11(10): 67-71Moss, A.J. 1986: Current status of calcium channel blocking drugs after myocardial infarction European Heart Journal 7 Suppl A: 31-34
Schwartz, A.; Taira, N. 1983: Calcium channel-blocking drugs: a novel intervention for the treatment of cardiac disease. Introduction Circulation Research 52(2 Pt 2): I1-I2
Raeburn, D. 1987: Calcium entry blocking drugs: their classification and sites of action in smooth muscle cells Medical Biology 65(4): 175-180
Yamamoto, N.; Nomura, M.; Okubo, K.; Maeda, K.; Goto, T. 1999: Pharmacologic characterization of FR172516: a new combined calcium channel-blocking and beta-adrenoceptor-blocking agent Journal of Cardiovascular Pharmacology 33(4): 587-594
Asano, M.; Uchida, W.; Shibasaki, K.; Terai, M.; Inagaki, O.; Takenaka, T.; Matsumoto, Y.; Fujikura, T. 1990: Pharmacological profiles of YM-16151-1 and its optical isomers: a novel calcium entry blocking and selective beta-1 adrenoceptor blocking agent Journal of Pharmacology and Experimental Therapeutics 254(1): 204-211
Krikler, D.M. 1988: Uses of calcium channel blocking agents and beta blocking agents in the control of supraventricular arrhythmias Progress in Clinical and Biological Research 275: 301-317
Imai, S. 1975: Action mechanism of anti-hypertensive drugs, with special reference to beta blocking drugs Nihon Jinzo Gakkai Shi 17(7): 674-677
Krum, H.; Pillay, P. 1998: New drugs, old drugs. Beta-adrenoceptor blocking agents Medical Journal of Australia 168(5): 232-235
Glossmann, H.; Ferry, D.R.; Goll, A.; Striessnig, J.; Zernig, G. 1985: Calcium channels and calcium channel drugs: recent biochemical and biophysical findings Arzneimittel-Forschung 35(12a): 1917-1935
Martiradonna, A.; Terlizzi, N.; D'Amore, M.; Pallante, R.; Carrozzo, M. 1981: Experimental osteoporosis caused by calcium deficiency in rats: treatment with calcium salts and synthetic anabolic drugs La Clinica Terapeutica 97(6): 587-604
Temkin, L.P. 1980: Calcium blocking agents. new directions in the treatment of angina pectoris Arizona Medicine 37(5): 328-333
Birx, D.L.; Berger, M.; Fleisher, T.A. 1984: The interference of T cell activation by calcium channel blocking agents Journal of Immunology 133(6): 2904-2909
Norman, J. 1979: Neuromuscular blocking drugs British Journal of Anaesthesia 51(6): 471-473
Barbato, F.; Grumetto, L.; Morrica, P. 1994: Analysis of calcium channel blocking dihydropyridines and their degradation products by gas chromatography Farmaco 49(7-8): 461-466
Slawin, S. 1973: Beta adrenergic blocking drugs Harefuah 85(4): 178-183
Taira, N.; Satoh, K.; Maruyama, M.; Yamashita, S. 1983: Sustained coronary constriction and its antagonism by calcium-blocking agents in monkeys and baboons Circulation Research 52(2 Part 2): I40-I46
Moretti, A.; Arcari, G.; Laterza, L.; Suchowsky, G.K. 1973: The effect of catecholamines and adrenergic blocking agents on the calcium and glycogen content in the rat heart Il Farmaco; Edizione Scientifica 28(1): 3-7
Cascone, A.; Ferrari, F.; Alaimo, A.; Daprati, A.; Cascone, G. 1985: Treatment of arterial hypertension with a calcium-channel blocking agent, nicardipine hydrochloride Bollettino Chimico Farmaceutico 124(5): 37S-42S
Schneider, W.; Kaltenback, M. 1988: The use of beta-blockers in unstable angina: comparison with calcium channel blocking agents Journal of Cardiovascular Pharmacology 12(Suppl 1): S78-S82